Marinus Pharmaceuticals Inc
(NASDAQ : MRNS)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SHPGShire PLC Sponsored ADR
-1.00%171.250.4%$136.39m
JAZZJazz Pharmaceuticals Plc
-0.35%176.492.2%$114.93m
SAGESAGE Therapeutics, Inc.
-0.04%168.569.6%$110.81m
PRGOPerrigo Co. Plc
0.16%75.956.7%$91.16m
ENDPEndo International Plc
-0.62%11.158.9%$71.94m
MNKMallinckrodt Plc
-1.03%21.6821.1%$69.05m
ICPTIntercept Pharmaceuticals, Inc.
-2.02%93.8021.8%$66.13m
ZGNXZogenix, Inc.
-0.93%58.4011.9%$66.12m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.61%146.226.8%$62.62m
CTLTCatalent Inc
1.48%43.982.6%$61.16m
MDCOMedicines Company
-0.70%39.8021.8%$38.54m
UTHRUnited Therapeutics Corporation
0.76%125.0314.4%$38.37m
SUPNSupernus Pharmaceuticals, Inc.
1.15%54.886.3%$36.47m
PTLAPortola Pharmaceuticals, Inc.
0.05%39.947.7%$34.31m
ICLRICON Plc
1.29%140.144.2%$31.48m

Company Profile

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.